IP Library › Granted Patent US 12,497,458
Granted Patent B2
US 12,497,458 · App. 17/813,578 · Granted Dec 16, 2025

Anti-GAL3 antibodies and uses thereof

Inventors: Dongxu Sun (Palo Alto, CA); Yan Wang (Concord, CA); Yinan Wu (San Carlos, CA); Catherine A. Gordon (Seattle, WA); Samuel A. F. Williams (Burlingame, CA)
Assignee: TrueBinding, Inc.
C07K16/2851A61K39/3955A61P35/00C07K2317/24C07K2317/565
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,497,458
App. No.
17/813,578
Granted
Dec 16, 2025
Kind
B2
Abstract

Disclosed herein are antibodies that specifically bind to Gal3 and methods of use thereof. In some embodiments, also described herein are methods of inducing immune activation or promoting T cell or Natural Killer cell proliferation with an antibody that specifically binds to Gal3. Also disclosed herein are methods and compositions of reducing fibrosis or propensity thereof in a tissue with antibodies that specifically bind to Gal3. In some cases, the anti-Gal3 antibody also disrupts the interaction between Gal3 and TIM-3.

Claims (59)

1 . An anti-GAL3 antibody or binding fragment thereof, wherein the anti-Gal3 antibody or binding fragment thereof comprises (1) a light chain variable region comprising a VL-CDR1, a VL-CDR2, and a VL-CDR3; and (2) a heavy chain variable region comprising a VH-CDR1, a VH-CDR2, and a VH-CDR3, wherein

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 37, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 65, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 93, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 121, the VL-CDR2 comprises an amino acid sequence comprising RMS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 177; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 38, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 66, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 94, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 122, the VL-CDR2 comprises an amino acid sequence comprising LVS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 178; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 39, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 67, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 95, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 123, the VL-CDR2 comprises an amino acid sequence comprising RMS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 179; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 40, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 68, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 96, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 124, the VL-CDR2 comprises an amino acid sequence comprising LVS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 180; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 41, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 69, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 97, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 125, the VL-CDR2 comprises an amino acid sequence comprising YTS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 181; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 42, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 70, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 98, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 126, the VL-CDR2 comprises an amino acid sequence comprising KVS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 182; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 43, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 71, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 99, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 127, the VL-CDR2 comprises an amino acid sequence comprising HAT, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 183; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 44, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 72, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 100, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 128, the VL-CDR2 comprises an amino acid sequence comprising LLS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 184; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 45, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 73, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 101, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 129, the VL-CDR2 comprises an amino acid sequence comprising GAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 185; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 46, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 74, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 102, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 130, the VL-CDR2 comprises an amino acid sequence comprising LVS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 186; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 47, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 75, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 103, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 131, the VL-CDR2 comprises an amino acid sequence comprising LVS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 187; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 48, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 76, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 104, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 132, the VL-CDR2 comprises an amino acid sequence comprising KVS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 188; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 49, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 77, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 105, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 133, the VL-CDR2 comprises an amino acid sequence comprising KAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 189; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 50, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 78, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 106, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 134, the VL-CDR2 comprises an amino acid sequence comprising YAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 190; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 51, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 79, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 107, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 135, the VL-CDR2 comprises an amino acid sequence comprising LVS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 191; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 52, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 80, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 108, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 136, the VL-CDR2 comprises an amino acid sequence comprising KAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 192; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 54, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 82, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 110, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 138, the VL-CDR2 comprises an amino acid sequence comprising YAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 194; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 55, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 83, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 111, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 139, the VL-CDR2 comprises an amino acid sequence comprising WAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 195; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 56, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 84, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 112, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 140, the VL-CDR2 comprises an amino acid sequence comprising WAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 196; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 57, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 85, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 113, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 141, the VL-CDR2 comprises an amino acid sequence comprising WAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 197; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 58, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 86, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 114, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 142, the VL-CDR2 comprises an amino acid sequence comprising LVC, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 198; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 59, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 87, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 115, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 143, the VL-CDR2 comprises an amino acid sequence comprising WAS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 199; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 61, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 89, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 117, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 145, the VL-CDR2 comprises an amino acid sequence comprising RMS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 201; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 63, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 91, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 119, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 147, the VL-CDR2 comprises an amino acid sequence comprising RMS, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 203; or

the VH-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 64, the VH-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 92, the VH-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 120, the VL-CDR1 comprises an amino acid sequence comprising SEQ ID NO: 148, the VL-CDR2 comprises an amino acid sequence comprising SEQ ID NO: 176, the VL-CDR3 comprises an amino acid sequence comprising SEQ ID NO: 204.

2 . An anti-GAL3 antibody or binding fragment thereof, wherein the antibody or binding fragment comprises:

a heavy chain sequence comprising SEQ ID NO: 205 and a light chain sequence comprising SEQ ID NO: 233; or

a heavy chain sequence comprising SEQ ID NO: 206 and a light chain sequence comprising SEQ ID NO: 234; or

a heavy chain sequence comprising SEQ ID NO: 207 and a light chain sequence comprising SEQ ID NO: 235; or

a heavy chain sequence comprising SEQ ID NO: 208 and a light chain sequence comprising SEQ ID NO: 236; or

a heavy chain sequence comprising SEQ ID NO: 209 and a light chain sequence comprising SEQ ID NO: 237; or

a heavy chain sequence comprising SEQ ID NO: 210 and a light chain sequence comprising SEQ ID NO: 238; or

a heavy chain sequence comprising SEQ ID NO: 211 and a light chain sequence comprising SEQ ID NO: 239; or

a heavy chain sequence comprising SEQ ID NO: 212 and a light chain sequence comprising SEQ ID NO: 240; or

a heavy chain sequence comprising SEQ ID NO: 213 and a light chain sequence comprising SEQ ID NO: 241; or

a heavy chain sequence comprising SEQ ID NO: 214 and a light chain sequence comprising SEQ ID NO: 242; or

a heavy chain sequence comprising SEQ ID NO: 215 and a light chain sequence comprising SEQ ID NO: 243; or

a heavy chain sequence comprising SEQ ID NO: 216 and a light chain sequence comprising SEQ ID NO: 244; or

a heavy chain sequence comprising SEQ ID NO: 217 and a light chain sequence comprising SEQ ID NO: 245; or

a heavy chain sequence comprising SEQ ID NO: 218 and a light chain sequence comprising SEQ ID NO: 246; or

a heavy chain sequence comprising SEQ ID NO: 219 and a light chain sequence comprising SEQ ID NO: 247; or

a heavy chain sequence comprising SEQ ID NO: 220 and a light chain sequence comprising SEQ ID NO: 248; or

a heavy chain sequence comprising SEQ ID NO: 222 and a light chain sequence comprising SEQ ID NO: 250; or

a heavy chain sequence comprising SEQ ID NO: 223 and a light chain sequence comprising SEQ ID NO: 251; or

a heavy chain sequence comprising SEQ ID NO: 224 and a light chain sequence comprising SEQ ID NO: 252; or

a heavy chain sequence comprising SEQ ID NO: 225 and a light chain sequence comprising SEQ ID NO: 253; or

a heavy chain sequence comprising SEQ ID NO: 226 and a light chain sequence comprising SEQ ID NO: 254; or

a heavy chain sequence comprising SEQ ID NO: 227 and a light chain sequence comprising SEQ ID NO: 255; or

a heavy chain sequence comprising SEQ ID NO: 229 and a light chain sequence comprising SEQ ID NO: 257; or

a heavy chain sequence comprising SEQ ID NO: 230 and a light chain sequence comprising SEQ ID NO: 258; or

a heavy chain sequence comprising SEQ ID NO: 231 and a light chain sequence comprising SEQ ID NO: 259; or

a heavy chain sequence comprising SEQ ID NO: 232 and a light chain sequence comprising SEQ ID NO: 260.

3 . A method of inducing immune activation, comprising:

contacting a plurality of cells comprising a Gal3-expressing cell and a TIM-3-expressing cell with the anti-Gal3 antibody of claim 1 under conditions to disrupt an interaction between Gal3 and TIM-3, wherein upon binding to the antibody, the Gal3-expressing cell expresses a cytokine which induces immune activation.

4 . A method of promoting T cell or Natural Killer (NK) cell proliferation, comprising:

contacting a plurality of cells comprising T cells, NK cells, and a Gal3-expressing cell with the anti-Gal3 antibody or binding fragment thereof of claim 1 under conditions to effect proliferation of T cells and/or NK cells in the plurality of cells.

5 . A method of inducing immune activation, comprising:

contacting a plurality of cells comprising a Gal3-expressing cell and a TIM-3-expressing cell with the anti-Gal3 antibody or binding fragment thereof of claim 1 under conditions to disrupt an interaction between Gal3 and TIM-3, wherein the Gal3-TIM-3 interaction is reduced to less than 70%, less than 60%, less than 59%, less than 50%, less than 40%, less than 34%, less than 30%, less than 20%, less than 14%, less than 10%, less than 7%, less than 5%, less than 4%, or less than 1%.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2023
From: SUN, DONGXU; WANG, YAN; GORDON, CATHERINE A.; WU, YINAN; WILLIAMS, SAMUEL A.F.
To: TRUEBINDING, INC.
Reel/Frame 064394/0094 →
Continuity (5)
Continuation 17384542 · Jul 23, 2021
Continuation PCTUS2020015692 · Jan 29, 2020
Provisional Application 62798945 · Jan 30, 2019
Provisional Application 62798949 · Jan 30, 2019
Related Publication 20220380473A1 · Dec 1, 2022
References Cited (400)
US 4179337A · Davis et al. · 1979 [cited by applicant]
US 4301144A · Iwashita et al. · 1981 [cited by applicant]
US 4495285A · Shimizu et al. · 1985 [cited by applicant]
US 4496689A · Mitra · 1985 [cited by applicant]
US 4609546A · Hiratani · 1986 [cited by applicant]
US 4640835A · Shimizu et al. · 1987 [cited by applicant]
US 4670417A · Iwasaki et al. · 1987 [cited by applicant]
US 4766106A · Katre et al. · 1988 [cited by applicant]
US 4791192A · Nakagawa et al. · 1988 [cited by applicant]
US 5208020A · Chari et al. · 1993 [cited by applicant]
US 5229275A · Goroff · 1993 [cited by applicant]
US 5270202A · Raychaudhuri · 1993 [cited by applicant]
US 5405783A · Pirrung et al. · 1995 [cited by applicant]
US 5416064A · Chari et al. · 1995 [cited by applicant]
US 5445934A · Fodor et al. · 1995 [cited by applicant]
US 5567610A · Borrebaeck et al. · 1996 [cited by applicant]
US 5624659A · Bigner et al. · 1997 [cited by applicant]
US 5695937A · Kinzler et al. · 1997 [cited by applicant]
US 5928885A · Nixon et al. · 1999 [cited by applicant]
US 5936078A · Kuga et al. · 1999 [cited by applicant]
US 5948626A · Hawkins et al. · 1999 [cited by applicant]
US 5968797A · Ni et al. · 1999 [cited by applicant]
US 5969108A · McCafferty et al. · 1999 [cited by applicant]
US 5985660A · Galy · 1999 [cited by applicant]
US 5994084A · Anderton et al. · 1999 [cited by applicant]
US 6087153A · Greenwald et al. · 2000 [cited by applicant]
US 6150584A · Kucherlapati et al. · 2000 [cited by applicant]
US 6156311A · Strickland et al. · 2000 [cited by applicant]
US 6162963A · Kucherlapati et al. · 2000 [cited by applicant]
US 6174708B1 · Sodoyer et al. · 2001 [cited by applicant]
US 6187287B1 · Leung et al. · 2001 [cited by applicant]
US 6242421B1 · Bowen et al. · 2001 [cited by applicant]
US 6255054B1 · Hugon et al. · 2001 [cited by applicant]
US 6303576B1 · Blaschuk et al. · 2001 [cited by applicant]
US 6562806B1 · Thurston et al. · 2003 [cited by applicant]
US 6576607B1 · Schachner · 2003 [cited by applicant]
US 6608192B1 · Thurston et al. · 2003 [cited by applicant]
US 6677116B1 · Blaschuk et al. · 2004 [cited by applicant]
US 6716821B2 · Zhao et al. · 2004 [cited by applicant]
US 6727075B2 · Fitzgerald et al. · 2004 [cited by applicant]
US 6821783B1 · Comely et al. · 2004 [cited by applicant]
US 6825164B1 · Stern et al. · 2004 [cited by applicant]
US 6852482B1 · Chrysler et al. · 2005 [cited by applicant]
US 6884869B2 · Senter et al. · 2005 [cited by applicant]
US 6982089B2 · Tobinick et al. · 2006 [cited by applicant]
US 7014855B2 · Schenk · 2006 [cited by applicant]
US 7029860B2 · Ota et al. · 2006 [cited by applicant]
US 7049311B1 · Thurston et al. · 2006 [cited by applicant]
US 7067511B2 · Thurston et al. · 2006 [cited by applicant]
US 7115260B2 · Dixit et al. · 2006 [cited by applicant]
US 7186681B2 · Liu et al. · 2007 [cited by applicant]
US 7214715B2 · Beck et al. · 2007 [cited by applicant]
US 7244724B2 · Liu et al. · 2007 [cited by applicant]
US 7270818B2 · Averback · 2007 [cited by applicant]
US 7276497B2 · Chari et al. · 2007 [cited by applicant]
US 7409040B2 · Cyrulnik · 2008 [cited by applicant]
US 7416855B2 · He et al. · 2008 [cited by applicant]
US 7485712B2 · Mandelkow et al. · 2009 [cited by applicant]
US 7498298B2 · Doronina et al. · 2009 [cited by applicant]
US 7528126B2 · Howard et al. · 2009 [cited by applicant]
US 7582732B2 · Horie et al. · 2009 [cited by applicant]
US 7611910B2 · Balin et al. · 2009 [cited by applicant]
US 7612062B2 · Gregson et al. · 2009 [cited by applicant]
US 7659241B2 · Senter et al. · 2010 [cited by applicant]
US 7662816B2 · Cumming et al. · 2010 [cited by applicant]
US 7700823B2 · Casas et al. · 2010 [cited by applicant]
US 7704924B2 · Thurston et al. · 2010 [cited by applicant]
US 7732568B2 · Mattner · 2010 [cited by applicant]
US 7750116B1 · Doronina et al. · 2010 [cited by applicant]
US 7846679B2 · St. George-Hyslop et al. · 2010 [cited by applicant]
US 7858642B2 · John et al. · 2010 [cited by applicant]
US 7910590B2 · Huang et al. · 2011 [cited by applicant]
US 7935252B2 · Mattner et al. · 2011 [cited by applicant]
US 7935348B2 · Mattner et al. · 2011 [cited by applicant]
US 7951373B2 · Schachner · 2011 [cited by applicant]
US 7955812B2 · Moir et al. · 2011 [cited by applicant]
US 7964566B2 · Doronina et al. · 2011 [cited by applicant]
US 7989597B2 · Chang et al. · 2011 [cited by applicant]
US 8008449B2 · Korman et al. · 2011 [cited by applicant]
US 8022180B2 · Mattner et al. · 2011 [cited by applicant]
US 8034353B2 · Yano et al. · 2011 [cited by applicant]
US 8060179B1 · Flynn · 2011 [cited by applicant]
US 8105597B2 · Davies et al. · 2012 [cited by applicant]
US 8105839B2 · Urakami et al. · 2012 [cited by applicant]
US 8163736B2 · Gauzy et al. · 2012 [cited by applicant]
US 8168188B1 · Hoshi et al. · 2012 [cited by applicant]
US 8173775B2 · Iwatsubo et al. · 2012 [cited by applicant]
US 8192954B2 · Klass et al. · 2012 [cited by applicant]
US 8222002B2 · Sugimura et al. · 2012 [cited by applicant]
US 8232373B2 · Wang · 2012 [cited by applicant]
US 8257740B1 · Sung et al. · 2012 [cited by applicant]
US 8263558B2 · Holzman et al. · 2012 [cited by applicant]
US 8288352B2 · Doronina et al. · 2012 [cited by applicant]
US 8318171B2 · Bush et al. · 2012 [cited by applicant]
US 8318687B2 · Tabira et al. · 2012 [cited by applicant]
US 8323925B2 · Chakravarthy · 2012 [cited by applicant]
US 8338379B2 · Yamaguchi et al. · 2012 [cited by applicant]
US 8343493B2 · VanMechelen et al. · 2013 [cited by applicant]
US 8349579B2 · Raz et al. · 2013 [cited by applicant]
US 8357781B2 · Johnson-Wooed et al. · 2013 [cited by applicant]
US 8394380B2 · Manucharyan et al. · 2013 [cited by applicant]
US 8404678B2 · Bouchard et al. · 2013 [cited by applicant]
US 8409575B2 · Lannfelt et al. · 2013 [cited by applicant]
US 8426402B2 · Li et al. · 2013 [cited by applicant]
US 8481701B2 · Jarrige et al. · 2013 [cited by applicant]
US 8487099B2 · Greenlee et al. · 2013 [cited by applicant]
US 8501934B2 · Howard et al. · 2013 [cited by applicant]
US 8518975B2 · Aslanian et al. · 2013 [cited by applicant]
US 8613920B2 · Lieberburg et al. · 2013 [cited by applicant]
US 8617549B2 · Sierks et al. · 2013 [cited by applicant]
US 8618123B2 · Sasikumar et al. · 2013 [cited by applicant]
US 8623365B2 · Davies et al. · 2014 [cited by applicant]
US 8633185B2 · Howard et al. · 2014 [cited by applicant]
US 8642044B2 · Schenk et al. · 2014 [cited by applicant]
US 8663650B2 · Nicolau et al. · 2014 [cited by applicant]
US 8664411B2 · Wu et al. · 2014 [cited by applicant]
US 8672857B2 · Muntendam · 2014 [cited by applicant]
US 8697688B2 · Howard et al. · 2014 [cited by applicant]
US 8703714B2 · Doronina et al. · 2014 [cited by applicant]
US 8710193B2 · Irie et al. · 2014 [cited by applicant]
US 8722042B2 · Relkin · 2014 [cited by applicant]
US 8748386B2 · Sigurdsson · 2014 [cited by applicant]
US 8764695B2 · Eliaz · 2014 [cited by applicant]
US 8778885B2 · Cashman et al. · 2014 [cited by applicant]
US 8784810B2 · Lieberburg et al. · 2014 [cited by applicant]
US 8796319B2 · Combs et al. · 2014 [cited by applicant]
US 8802667B2 · Li et al. · 2014 [cited by applicant]
US 8809010B2 · Hoffmann et al. · 2014 [cited by applicant]
US 8809320B2 · Li et al. · 2014 [cited by applicant]
US 8852874B2 · Olas et al. · 2014 [cited by applicant]
US 8871720B2 · Doronina et al. · 2014 [cited by applicant]
US 8877192B2 · Mjalli et al. · 2014 [cited by applicant]
US 8877207B2 · Cimini et al. · 2014 [cited by applicant]
US 8912145B2 · Terakawa et al. · 2014 [cited by applicant]
US 8933295B2 · Jung et al. · 2015 [cited by applicant]
US 8936910B2 · Mitsch et al. · 2015 [cited by applicant]
US 8951747B2 · Demotte et al. · 2015 [cited by applicant]
US 8993833B2 · Colton et al. · 2015 [cited by applicant]
US 9034334B2 · Gellerfors et al. · 2015 [cited by applicant]
US 9066928B1 · Estus et al. · 2015 [cited by applicant]
US 9089614B2 · Lin et al. · 2015 [cited by applicant]
US 9133267B2 · Lee et al. · 2015 [cited by applicant]
US 9163062B2 · Sarasa Barrio · 2015 [cited by applicant]
US 9173928B2 · Matsumoto · 2015 [cited by applicant]
US 9217036B2 · Strittmatter et al. · 2015 [cited by applicant]
US 9234038B2 · Jung et al. · 2016 [cited by applicant]
US 9239333B2 · Snider · 2016 [cited by applicant]
US 9242013B2 · Howard et al. · 2016 [cited by applicant]
US 9295707B2 · Shashoua · 2016 [cited by applicant]
US 9320436B2 · Russmann et al. · 2016 [cited by applicant]
US 9347085B2 · Gan et al. · 2016 [cited by applicant]
US 9382316B2 · Yoon · 2016 [cited by applicant]
US 9580494B2 · Shafer et al. · 2017 [cited by applicant]
US 9618511B2 · Querfurth · 2017 [cited by applicant]
US 9637552B2 · Cashman et al. · 2017 [cited by applicant]
US 9645155B2 · Cai et al. · 2017 [cited by applicant]
US 9737505B2 · Denis et al. · 2017 [cited by applicant]
US 9751912B2 · Hoshi · 2017 [cited by applicant]
US 9757398B2 · Vigo et al. · 2017 [cited by applicant]
US 9777056B2 · Sigurdsson et al. · 2017 [cited by applicant]
US 9790253B2 · Shair et al. · 2017 [cited by applicant]
US 9821114B2 · Cabrera Aquino et al. · 2017 [cited by applicant]
US 9879076B2 · Samira et al. · 2018 [cited by applicant]
US 9903855B2 · Cheresh et al. · 2018 [cited by applicant]
US 9907485B2 · Hartlep et al. · 2018 [cited by applicant]
US 9921230B2 · Chodobski et al. · 2018 [cited by applicant]
US 9933440B2 · Goetzl · 2018 [cited by applicant]
US 9937248B2 · Arya · 2018 [cited by applicant]
US 9999624B2 · May et al. · 2018 [cited by applicant]
US 10011653B2 · Hayashi et al. · 2018 [cited by applicant]
US 10028962B2 · Brodney et al. · 2018 [cited by applicant]
US 10117895B2 · Monsonego · 2018 [cited by applicant]
US 10131708B2 · Nitsch et al. · 2018 [cited by applicant]
US 10203342B2 · Goetzl · 2019 [cited by applicant]
US 10213462B2 · Eliaz · 2019 [cited by applicant]
US 10232056B2 · Uchida et al. · 2019 [cited by applicant]
US 10282349B2 · Jaffee · 2019 [cited by applicant]
US 10323084B2 · Hillen et al. · 2019 [cited by applicant]
US 10358503B2 · Sigurdsson · 2019 [cited by applicant]
US 10364286B2 · Fog et al. · 2019 [cited by applicant]
US 10377834B2 · De Strooper et al. · 2019 [cited by applicant]
US 10393757B2 · Hashimoto et al. · 2019 [cited by applicant]
US 10420923B1 · Katz · 2019 [cited by applicant]
US 10421958B2 · Poma et al. · 2019 [cited by applicant]
US 10472414B2 · Christensen et al. · 2019 [cited by applicant]
US 10473672B2 · Lin et al. · 2019 [cited by applicant]
US 10532104B2 · Elmaleh · 2020 [cited by applicant]
US 10570196B2 · Ghochikyan et al. · 2020 [cited by applicant]
US 10654917B2 · Volker et al. · 2020 [cited by applicant]
US 10662226B2 · Nowick et al. · 2020 [cited by applicant]
US 10662239B2 · Groves et al. · 2020 [cited by applicant]
US 10662246B2 · Wisniewski et al. · 2020 [cited by applicant]
US 10670613B2 · Umek et al. · 2020 [cited by applicant]
US 10718785B2 · Pike et al. · 2020 [cited by applicant]
US 10730937B2 · Okazawa et al. · 2020 [cited by applicant]
US 10738107B2 · Gnauer et al. · 2020 [cited by applicant]
US 10792349B2 · Jaffee · 2020 [cited by applicant]
US 10815230B2 · Pike et al. · 2020 [cited by applicant]
US 10815469B2 · Poma et al. · 2020 [cited by applicant]
US 10822402B2 · Dengl et al. · 2020 [cited by applicant]
US 10828413B2 · Eliaz · 2020 [cited by applicant]
US 10836814B2 · Goshima et al. · 2020 [cited by applicant]
US 10837966B2 · Hodi et al. · 2020 [cited by applicant]
US 10842871B2 · Ferrero et al. · 2020 [cited by applicant]
US 10851156B2 · Mercken et al. · 2020 [cited by applicant]
US 10859582B2 · Sigurdsson et al. · 2020 [cited by applicant]
US 10874725B2 · Henco et al. · 2020 [cited by applicant]
US 10888600B2 · Tanzi et al. · 2021 [cited by applicant]
US 10894822B2 · Chain · 2021 [cited by applicant]
US 10919971B2 · Collinge et al. · 2021 [cited by applicant]
US 10934348B2 · Pedersen et al. · 2021 [cited by applicant]
US 10941205B2 · Duerr et al. · 2021 [cited by applicant]
US 10941215B2 · Dennis et al. · 2021 [cited by applicant]
US 10954306B2 · Greenfield et al. · 2021 [cited by applicant]
US 10976319B2 · Pugia · 2021 [cited by applicant]
US 10981989B2 · Eisenbach et al. · 2021 [cited by applicant]
US 10988528B2 · Sigurdsson · 2021 [cited by applicant]
US 11084873B2 · Shie et al. · 2021 [cited by applicant]
US 11085935B2 · Barthelemy et al. · 2021 [cited by applicant]
US 11091552B2 · Fontayne et al. · 2021 [cited by applicant]
US 11098106B2 · Novák et al. · 2021 [cited by applicant]
US 11111290B2 · Pedersen et al. · 2021 [cited by applicant]
US 11135313B2 · Wilson et al. · 2021 [cited by applicant]
US 11181533B2 · Shi et al. · 2021 [cited by applicant]
US 11214835B1 · Patel et al. · 2022 [cited by applicant]
US 11219627B2 · Davis et al. · 2022 [cited by applicant]
US 11236155B2 · Van et al. · 2022 [cited by applicant]
US 11278620B2 · Liang et al. · 2022 [cited by applicant]
US 11286297B2 · Groves et al. · 2022 [cited by applicant]
US 11312751B2 · Poma et al. · 2022 [cited by applicant]
US 11319372B2 · Calzone et al. · 2022 [cited by applicant]
US 11365223B2 · Poma et al. · 2022 [cited by applicant]
US 11370833B2 · Le et al. · 2022 [cited by applicant]
US 11389476B2 · Eliaz · 2022 [cited by applicant]
US 11395796B2 · Romanelli et al. · 2022 [cited by applicant]
US 11396553B2 · Oostindie et al. · 2022 [cited by applicant]
US 11413282B2 · Sampath et al. · 2022 [cited by applicant]
US 11427638B2 · Sun · 2022 [cited by examiner]
US 11434302B2 · Raum et al. · 2022 [cited by applicant]
US 11439665B2 · Yao et al. · 2022 [cited by applicant]
US 11446398B2 · Barrett et al. · 2022 [cited by applicant]
US 11459404B2 · Bacac et al. · 2022 [cited by applicant]
US 11459405B2 · Sasisekharan et al. · 2022 [cited by applicant]
US 11466099B2 · Garcia et al. · 2022 [cited by applicant]
US 11471490B2 · Andresen et al. · 2022 [cited by applicant]
US 11472858B2 · Yao et al. · 2022 [cited by applicant]
US 11478554B2 · Lerchen et al. · 2022 [cited by applicant]
US 11505609B2 · Qin et al. · 2022 [cited by applicant]
US 11512137B2 · Oostindie et al. · 2022 [cited by applicant]
US 11518810B2 · Song et al. · 2022 [cited by applicant]
US 11525007B2 · Bruenker et al. · 2022 [cited by applicant]
US 11535838B2 · Rosenblum et al. · 2022 [cited by applicant]
US 11583594B2 · Xie · 2023 [cited by applicant]
US 11584793B2 · Dengl et al. · 2023 [cited by applicant]
US 11590128B2 · Sampath et al. · 2023 [cited by applicant]
US 11596699B2 · Fotin-Mleczek · 2023 [cited by applicant]
US 11597772B2 · Oestergaard et al. · 2023 [cited by applicant]
US 11603411B2 · Duerr et al. · 2023 [cited by applicant]
US 11608369B2 · Yao et al. · 2023 [cited by applicant]
US 11608376B2 · Georges et al. · 2023 [cited by applicant]
US 11618778B2 · Yao et al. · 2023 [cited by applicant]
US 11633430B2 · Yao et al. · 2023 [cited by applicant]
US 11634486B2 · Jefferies et al. · 2023 [cited by applicant]
US 11654143B2 · Hamdy et al. · 2023 [cited by applicant]
US 11660351B2 · Lerchen et al. · 2023 [cited by applicant]
US 11666642B2 · Suri et al. · 2023 [cited by applicant]
US 11679127B2 · Stubenrauch et al. · 2023 [cited by applicant]
US 11685714B2 · Lerchen et al. · 2023 [cited by applicant]
US 11713358B2 · Schellenberger et al. · 2023 [cited by applicant]
US 11718680B2 · Bacac et al. · 2023 [cited by applicant]
US 11746161B2 · Chen et al. · 2023 [cited by applicant]
US 11753466B2 · West et al. · 2023 [cited by applicant]
US 11768203B2 · Chaudhary · 2023 [cited by applicant]
US 11771696B2 · Hamdy et al. · 2023 [cited by applicant]
US 11788205B2 · Klein et al. · 2023 [cited by applicant]
US 11833214B2 · Hilderbrand et al. · 2023 [cited by applicant]
US 11857628B2 · Poma et al. · 2024 [cited by applicant]
US 11866507B2 · Eckelman · 2024 [cited by applicant]
US 11867696B2 · Schwartz · 2024 [cited by applicant]
US 11873332B2 · Soto et al. · 2024 [cited by applicant]
US 11873342B2 · Li et al. · 2024 [cited by applicant]
US 11891444B2 · Gauthier et al. · 2024 [cited by applicant]
US 11912759B2 · Liu et al. · 2024 [cited by applicant]
US 11913945B2 · Schaefer et al. · 2024 [cited by applicant]
US 12227567B2 · Sun · 2025 [cited by examiner]
US 20020076738A1 · Woo · 2002 [cited by applicant]
US 20020155513A1 · Hsu et al. · 2002 [cited by applicant]
US 20030133939A1 · Ledbetter et al. · 2003 [cited by applicant]
US 20040223971A1 · Chang et al. · 2004 [cited by applicant]
US 20050032673A1 · John et al. · 2005 [cited by applicant]
US 20050084915A1 · Woo · 2005 [cited by applicant]
US 20050158321A1 · Hurez et al. · 2005 [cited by applicant]
US 20060148712A1 · Liu et al. · 2006 [cited by applicant]
US 20060240551A1 · Jiang · 2006 [cited by applicant]
US 20060246496A1 · Ahmed et al. · 2006 [cited by applicant]
US 20060257359A1 · Francois et al. · 2006 [cited by applicant]
US 20060257946A1 · Ding et al. · 2006 [cited by applicant]
US 20080219973A1 · Sasaki et al. · 2008 [cited by applicant]
US 20090269779A1 · Raz et al. · 2009 [cited by applicant]
US 20090280116A1 · Smith et al. · 2009 [cited by applicant]
US 20090311193A1 · Mauro et al. · 2009 [cited by applicant]
US 20100061992A1 · Anderson et al. · 2010 [cited by applicant]
US 20100098683A1 · Kufe · 2010 [cited by applicant]
US 20100104587A1 · Chavan et al. · 2010 [cited by applicant]
US 20100143954A1 · Muntendam · 2010 [cited by applicant]
US 20100196882A1 · Raz et al. · 2010 [cited by applicant]
US 20100330602A1 · Van Meir et al. · 2010 [cited by applicant]
US 20110038861A1 · Rosenthal et al. · 2011 [cited by applicant]
US 20110293608A1 · Jaffee · 2011 [cited by applicant]
US 20120046181A1 · Harb et al. · 2012 [cited by applicant]
US 20120225114A1 · Francois et al. · 2012 [cited by applicant]
US 20120253160A1 · Mauro et al. · 2012 [cited by applicant]
US 20130017998A1 · Nishi et al. · 2013 [cited by applicant]
US 20130029900A1 · Widdison · 2013 [cited by applicant]
US 20130029955A1 · Muntendam · 2013 [cited by applicant]
US 20130045882A1 · Klass et al. · 2013 [cited by applicant]
US 20130065258A1 · Watanabe et al. · 2013 [cited by applicant]
US 20130323268A1 · Chari et al. · 2013 [cited by applicant]
US 20140086836A1 · Burnham et al. · 2014 [cited by applicant]
US 20140086932A1 · Traber · 2014 [cited by applicant]
US 20140099254A1 · Chang et al. · 2014 [cited by applicant]
US 20140105997A1 · Eliaz · 2014 [cited by applicant]
US 20140235495A1 · Pugia · 2014 [cited by applicant]
US 20140286970A1 · Jeffrey et al. · 2014 [cited by applicant]
US 20140294862A1 · Chavan et al. · 2014 [cited by applicant]
US 20140294868A1 · Howard et al. · 2014 [cited by applicant]
US 20140370521A1 · Porter et al. · 2014 [cited by applicant]
US 20150105539A1 · Miao et al. · 2015 [cited by applicant]
US 20150105540A1 · Miao et al. · 2015 [cited by applicant]
US 20150150945A1 · Francois et al. · 2015 [cited by applicant]
US 20150218274A1 · Sabatos-Peyton et al. · 2015 [cited by applicant]
US 20150301058A1 · Schettini et al. · 2015 [cited by applicant]
US 20150329636A1 · Dennis et al. · 2015 [cited by applicant]
US 20150377905A1 · Burns et al. · 2015 [cited by applicant]
US 20160068577A1 · Poma et al. · 2016 [cited by applicant]
US 20160166686A1 · McNeel et al. · 2016 [cited by applicant]
US 20160177284A1 · Poma et al. · 2016 [cited by applicant]
US 20160199470A1 · Chavan et al. · 2016 [cited by applicant]
US 20160376328A1 · Poma et al. · 2016 [cited by applicant]
US 20170002046A1 · Poma et al. · 2017 [cited by applicant]
US 20170014446A1 · Rolke et al. · 2017 [cited by applicant]
US 20170056498A1 · Krause et al. · 2017 [cited by applicant]
US 20170153241A1 · Pugia · 2017 [cited by applicant]
US 20170275353A1 · Sheng et al. · 2017 [cited by applicant]
US 20170355756A1 · Julien · 2017 [cited by applicant]
US 20170363620A1 · Beshiri et al. · 2017 [cited by applicant]
US 20170363637A1 · Takata et al. · 2017 [cited by applicant]
US 20170370944A1 · Muntendam et al. · 2017 [cited by applicant]
US 20180000899A1 · Francois et al. · 2018 [cited by applicant]
US 20180243432A1 · Poma et al. · 2018 [cited by applicant]
US 20180256747A1 · Hawthorne et al. · 2018 [cited by applicant]
US 20180291359A1 · Poma et al. · 2018 [cited by applicant]
US 20190153044A1 · Poma et al. · 2019 [cited by applicant]
US 20190175649A1 · Novik · 2019 [cited by applicant]
US 20190218300A1 · Del Rio et al. · 2019 [cited by applicant]
US 20190248902A1 · Nioi · 2019 [cited by applicant]
US 20190265235A1 · Schwartz et al. · 2019 [cited by applicant]
US 20190374650A1 · Moon et al. · 2019 [cited by applicant]
US 20200024312A1 · Poma et al. · 2020 [cited by applicant]
US 20200055938A1 · Desai · 2020 [cited by applicant]
US 20200078398A1 · Eliaz · 2020 [cited by applicant]
US 20200085866A1 · Eliaz · 2020 [cited by applicant]
US 20200085867A1 · Eliaz · 2020 [cited by applicant]
US 20200223921A1 · Sun · 2020 [cited by examiner]
US 20210001032A1 · Eliaz · 2021 [cited by applicant]
US 20210032350A1 · Spriggs et al. · 2021 [cited by applicant]
US 20210102948A1 · Hodi et al. · 2021 [cited by applicant]
US 20210115123A1 · Sheng et al. · 2021 [cited by applicant]
US 20210132067A1 · Schwartz · 2021 [cited by applicant]
US 20210177794A1 · Steineger et al. · 2021 [cited by applicant]
US 20210246211A1 · Goldberg et al. · 2021 [cited by applicant]
US 20210324056A1 · Luthman et al. · 2021 [cited by applicant]
US 20210363255A1 · Sun et al. · 2021 [cited by applicant]
US 20210371533A1 · Sun et al. · 2021 [cited by applicant]
US 20210401985A1 · Biel et al. · 2021 [cited by applicant]
US 20220025071A1 · Capon · 2022 [cited by applicant]
US 20220040172A1 · Li et al. · 2022 [cited by applicant]
US 20220088013A1 · Hamdy et al. · 2022 [cited by applicant]
US 20220088195A1 · Klein et al. · 2022 [cited by applicant]
US 20220098329A1 · Santich et al. · 2022 [cited by applicant]
US 20220125942A1 · Musick et al. · 2022 [cited by applicant]
US 20220127366A1 · Fotakis et al. · 2022 [cited by applicant]
US 20220133711A1 · Chari et al. · 2022 [cited by applicant]
US 20220135678A1 · Chaudhary · 2022 [cited by applicant]
US 20220162316A1 · Pandit et al. · 2022 [cited by applicant]
US 20220168418A1 · Haefel et al. · 2022 [cited by applicant]
US 20220184127A1 · Wang et al. · 2022 [cited by applicant]
US 20220195043A1 · Li et al. · 2022 [cited by applicant]
US 20220195057A1 · Li et al. · 2022 [cited by applicant]
US 20220195071A1 · Jones · 2022 [cited by applicant]
US 20220204582A1 · Chaudhary · 2022 [cited by applicant]
US 20220211696A1 · Sampath et al. · 2022 [cited by applicant]
US 20220211865A1 · Fischer et al. · 2022 [cited by applicant]
US 20220226514A1 · Vasiljeva et al. · 2022 [cited by applicant]
US 20220233705A1 · Le Scolan et al. · 2022 [cited by applicant]
US 20220242936A1 · Feng et al. · 2022 [cited by applicant]
US 20220242949A1 · Desnoyers et al. · 2022 [cited by applicant]
US 20220244271A1 · Reed et al. · 2022 [cited by applicant]
US 20220251231A1 · Oostindie et al. · 2022 [cited by applicant]
US 20220257762A1 · Liang et al. · 2022 [cited by applicant]
Cited By (1)
US 12,655,221